Targeted neoadjuvant therapy in the HER-2-positive breast cancer patients: a systematic review and meta-analysis

Wenhua Ma,Fugang Zhao,Changpeng Zhou,Yongqian Zhang,Yingchun Zhao,Na Li,Peng Xie

Targeted neoadjuvant therapy in the HER-2-positive breast cancer patients: a systematic review and meta-analysis

2019

Wenhua Ma
Fugang Zhao
Changpeng Zhou
Yongqian Zhang
Yingchun Zhao
Na Li
Peng Xie

Aim To evaluate efficacy and safety of lapatinib or trastuzumab alone or both plus chemotherapy for the treatment of breast cancer patients with positive HER-2 expression.

Keywords:

Breast cancer
Pathology
Neoadjuvant therapy
Medicine
Immunology
Lapatinib
Pertuzumab
Oncology
Internal medicine
Rash
Chemotherapy
Adverse effect
Trastuzumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations